Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T03:16:22.897Z Has data issue: false hasContentIssue false
  • English
  • Français

A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder

Published online by Cambridge University Press:  13 May 2010

D. Koszycki ,
M. Taljaard ,
Z. Segal  and
J. Bradwejn
D. Koszycki*
Affiliation:
Faculty of Education, University of Ottawa, ON, Canada Department of Psychiatry, University of Ottawa, ON, Canada
M. Taljaard
Affiliation:
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada Department of Epidemiology and Community Medicine, University of Ottawa, ON, Canada
Z. Segal
Affiliation:
Departments of Psychiatry and Psychology, University of Toronto and Centre for Addiction and Mental Health, Toronto, ON, Canada
J. Bradwejn
Affiliation:
Department of Psychiatry, University of Ottawa, ON, Canada
*
*Address for correspondence: D. Koszycki. Ph.D., C.Psych., Faculty of Education, University of Ottawa, 145 Jean-Jacques Lussier, Ottawa, Ontario, K1N 6N5, Canada. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Self-administered cognitive behavior therapy (SCBT) has been shown to be an effective alternative to therapist-delivered treatment for panic disorder (PD). However, it is unknown whether combining SCBT and antidepressants can improve treatment. This trial evaluated the efficacy of SCBT and sertraline, alone or in combination, in PD.

Method

Patients (n=251) were randomized to 12 weeks of either placebo drug, placebo drug plus SCBT, sertraline, or sertraline plus SCBT. Those who improved after 12 weeks of acute treatment received treatment for an additional 12 weeks. Outcome measures included core PD symptoms (panic attacks, anticipatory anxiety, agoraphobic avoidance), dysfunctional cognitions (fear of bodily sensations, agoraphobic cognitions), disability, and clinical global impression of severity and improvement. Efficacy data were analyzed using general and generalized linear mixed models.

Results

Primary analyses of trends over time revealed that sertraline/SCBT produced a significantly greater rate of decline in fear of bodily sensations compared to sertraline, placebo/SCBT and placebo. Trends in other outcomes were not significantly different over time. Secondary analyses of mean scores at week 12 revealed that sertraline/SCBT fared better on several outcomes than placebo, with improvement being maintained at the end of continuation treatment. Outcome did not differ between placebo and either sertraline monotherapy or placebo/SCBT. Moreover, few differences emerged between the active interventions.

Conclusions

This trial suggests that sertraline combined with SCBT may be an effective treatment for PD. The study could not confirm the efficacy of sertraline monotherapy or SCBT without concomitant medication or therapist assistance in the treatment of PD.

Keywords

Cognitive behavior therapy (CBT)combination treatmentpanic disorderself-help interventionsSSRI
Type
Original Articles
Information
Psychological Medicine , Volume 41 , Issue 2 , February 2011 , pp. 373 - 383
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bakker, A, van Balkom, AJ, Stein, DJ (2005). Evidence-based pharmacotherapy of panic disorder. International Journal of Neuropsychopharmacology 8, 473–482.CrossRefGoogle ScholarPubMed
Carlbring, P, Ekselius, L, Andersson, G (2003). Treatment of panic disorder via the Internet: a randomized trail of CBT vs applied relaxation. Journal of Behavior Therapy and Experimental Research 34, 129–140.Google Scholar
Carlbring, P, Nillsson-Ihrfelt, E, Waara, J, Kollenstam, C, Burman, M, Kaldo, V, Soderberg, M, Ekselius, L, Anderson, G (2005). Treatment of panic disorder: live therapy vs. self-help via internet. Behaviour Research and Therapy 43, 1321–1333.CrossRefGoogle ScholarPubMed
Carlbring, P, Westling, BE, Ljungstrad, P, Ekselius, L, Andersson, G (2001). Treatment of panic disorder via the Internet: A randomized trial of a self-help intervention. Behaviour Therapy 32, 751–764.CrossRefGoogle Scholar
Chambless, DL, Caputo, GC, Bright, P, Gallagher, R (1984). Assessment of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. Journal of Consulting and Clinical Psychology 52, 1090–1097.CrossRefGoogle ScholarPubMed
Chambless, DL, Caputo, GC, Jasin, SE, Gracely, EJ, Williams, C (1985). The Mobility Inventory for Agoraphobia. Behaviour Research and Therapy 23, 35–44.CrossRefGoogle ScholarPubMed
Craske, MG, Zucker, BG (2001). Consideration of the APA practice guideline for the treatment of patients with panic disorders: strengths and limitations of behavior therapy. Behavior Therapy 32, 259–281.CrossRefGoogle Scholar
Fawcett, J, Epstein, P, Fiester, SJ, Elkin, I, Autry, JH (1987). Clinical management – imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacology Bulletin 23, 309–324.Google ScholarPubMed
Febbraro, GA (2005). An investigation into the effectiveness of bibliotherapy and minimal contact interventions in the treatment of panic attacks. Journal of Clinical Psychology 61, 763–779.CrossRefGoogle ScholarPubMed
Febbraro, GA, Clum, GA, Roodman, AA, Wright, JH (1999). The limits of bibliotherapy: a study of the differential effectiveness of self-administered interventions in individuals with panic attacks. Behavior Therapy 30, 209–222.CrossRefGoogle Scholar
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW (1997). Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. American Psychiatric Publishing, Inc: Washington, DC.Google Scholar
Furukawa, TA, Watanabe, N, Churchill, R (2006). Psychotherapy plus antidepressants for panic disorder with or without agoraphobia. British Journal of Psychiatry 188, 305–312.CrossRefGoogle ScholarPubMed
Furukawa, TA, Watanabe, N, Omori, IM, Churchill, R (2007). Can pill placebo augment cognitive-behavior therapy for panic disorder? BMC Psychiatry 7, 73.CrossRefGoogle ScholarPubMed
Gould, RA, Clum, GA (1995). Self-help plus minimal therapist contact in the treatment of panic disorder: a replication and extension. Behavior Therapy 26, 533–546.CrossRefGoogle Scholar
Gould, RA, Clum, GA, Shapiro, D (1993). The use of bibliotherapy in the treatment of panic: a preliminary investigation. Behavior Therapy 24, 241–252.CrossRefGoogle Scholar
Guy, W (1976). ECDEU Assessment Manual for Psychopharmacology – Revised, pp. 218–222. Publication ADM 76-338. National Institute of Mental Health: Rockville, MD.Google Scholar
Hamilton, M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56–62.CrossRefGoogle ScholarPubMed
Hecker, JE, Losee, MC, Fritzler, BK, Fink, CM (1996). Self-directed versus therapist-directed cognitive behavioral treatment for panic disorder. Journal of Anxiety Disorders 10, 253–265.CrossRefGoogle Scholar
Holden, AE, O'Brien, GT, Barlow, DH, Stetson, D, Infantino, A (1983). Self-help manual for agoraphobia: a preliminary report of effectiveness. Behavior Therapy 15, 545–556.CrossRefGoogle Scholar
Kiropoulos, LA, Klein, B, Austin, DW, Gilson, K, Pier, C, Mitchell, J, Ciechomski, L (2008). Is internet-based CBT for panic disorder and agoraphobia as effective as fact-to-fact CBT? Journal of Anxiety Disorder 22, 1273–1284.CrossRefGoogle ScholarPubMed
Lidren, DM, Watkins, PL, Gould, RA, Clum, GA, Asterino, M, Tulloch, HL (1994). A comparison of bibliotherapy and group therapy in the treatment of panic disorder. Journal of Consulting and Clinical Psychology 62, 865–869.CrossRefGoogle ScholarPubMed
Littell, RC, Milliken, GA, Stroup, WW, Wolfinger, RD, Schabenberber, O (2006). SAS for Mixed Models, 2nd edn, p. 814. SAS Institute Inc.: Cary, NC.Google Scholar
Londborg, PD, Wolkow, R, Smith, WT, DuBoff, E, England, D, Ferguson, J, Rosenthal, M, Weise, C (1998). Sertraline in the treatment of panic disorder: a multi-site, double-blind, placebo-controlled, fixed-dose investigation. British Journal of Psychiatry 173, 54–60.CrossRefGoogle ScholarPubMed
Marks, IM, Kenwright, M, McDonough, M, Whittaker, M, Mataix-Cols, D (2004). Saving clinicians' time by delegating routine aspects of therapy to a computer: a randomized controlled trial in phobia/panic disorder. Psychological Medicine 34, 9–17.CrossRefGoogle ScholarPubMed
McAlister, FA, Straus, SD, Sackett, DL, Altman, DG (2003). Analysis and reporting of factorial trials: a systematic review. Journal of the American Medical Association 289, 2545–2575.CrossRefGoogle ScholarPubMed
National Institutes of Health (1991). Treatment of Panic Disorder. National Institutes of Health Consensus Development Conference Statement September 25–27, 9, 1–24.Google Scholar
Ott, MB, Yingling, GL (2006). Guide to Good Clinical Practice. Thompson Publishing Group Inc.: Washington, DC.Google Scholar
Park, JM, Mataix-Cols, D, Marks, IM, Ngamthipwatthana, T, Marks, M, Araya, R, Al Kubaisy, T (2001). Two-year follow-up after a randomised controlled trial of self- and clinician-accompanied exposure for phobia/panic disorders. British Journal of Psychiatry 178, 543–548.CrossRefGoogle ScholarPubMed
Pohl, RB, Wolkow, RM, Clary, CM (1998). Sertraline in the treatment of panic disorder: a double-blind multicenter trial. American Journal of Psychiatry 155, 1189–1195.CrossRefGoogle ScholarPubMed
Pollack, MH, Otto, MW, Worthington, JJ, Manfro, GG, Wolkow, R (1998). Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Archives of General Psychiatry 55, 1010–1016.CrossRefGoogle ScholarPubMed
Pollack, MM, Rappaport, MH, Clary, CM, Mardelian, J, Wolkow, R (2000). Sertraline treatment and panic disorder: response in patients at risk for poor outcome. Journal of Clinical Psychiatry 61, 922–927.CrossRefGoogle ScholarPubMed
Proschan, MA, Waclawiw, MA (2000). Practical guidelines for multiplicity adjustment in clinical trials. Controlled Clinical Trials 21, 527–539.CrossRefGoogle ScholarPubMed
Shear, K, Maser, JD (1994). Standardized assessment for panic disorder research. A conference report. Archives of General Psychiatry 51, 346–354.CrossRefGoogle ScholarPubMed
Sheehan, DV, Harnett-Sheehan, K, Raj, BA (1996). The measurement of disability. International Clinical Psychopharmacology 57 (Suppl. 10), 89–95.CrossRefGoogle Scholar